These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1575 related items for PubMed ID: 15896197

  • 21. The role of innate immune responses in autoimmune disease development.
    Waldner H.
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [Abstract] [Full Text] [Related]

  • 22. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S.
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [Abstract] [Full Text] [Related]

  • 23. The 'kiss of death' by dendritic cells to cancer cells.
    Chan CW, Housseau F.
    Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis.
    Novak N, Koch S, Allam JP, Bieber T.
    J Allergy Clin Immunol; 2010 Jan; 125(1):50-9. PubMed ID: 20109736
    [Abstract] [Full Text] [Related]

  • 26. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects.
    Alvarez-Pellitero P.
    Vet Immunol Immunopathol; 2008 Dec 15; 126(3-4):171-98. PubMed ID: 18783835
    [Abstract] [Full Text] [Related]

  • 27. Toll-like receptor control of the adaptive immune responses.
    Iwasaki A, Medzhitov R.
    Nat Immunol; 2004 Oct 15; 5(10):987-95. PubMed ID: 15454922
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B, Navabi H, Adams M.
    Vaccine; 2009 May 26; 27(25-26):3401-4. PubMed ID: 19200817
    [Abstract] [Full Text] [Related]

  • 30. Fc-receptors as regulators of immunity.
    Nimmerjahn F, Ravetch JV.
    Adv Immunol; 2007 May 26; 96():179-204. PubMed ID: 17981207
    [Abstract] [Full Text] [Related]

  • 31. Orchestrating innate immune responses in multiple sclerosis: molecular players.
    Fernández M, Montalban X, Comabella M.
    J Neuroimmunol; 2010 Aug 25; 225(1-2):5-12. PubMed ID: 20537409
    [Abstract] [Full Text] [Related]

  • 32. [Recognition mechanism of pathogen-associated molecular patterns and role of innate immune lymphocytes in fungal infection].
    Kawakami K.
    Rinsho Byori; 2009 Aug 25; 57(8):779-85. PubMed ID: 19764413
    [Abstract] [Full Text] [Related]

  • 33. The immunogenicity of dendritic cell-derived exosomes.
    Quah BJ, O'Neill HC.
    Blood Cells Mol Dis; 2005 Aug 25; 35(2):94-110. PubMed ID: 15975838
    [Abstract] [Full Text] [Related]

  • 34. A central role for tissue-resident dendritic cells in innate responses.
    Foti M, Granucci F, Ricciardi-Castagnoli P.
    Trends Immunol; 2004 Dec 25; 25(12):650-4. PubMed ID: 15530834
    [Abstract] [Full Text] [Related]

  • 35. New biodefense strategies by neutrophils.
    Ishikawa F, Miyazaki S.
    Arch Immunol Ther Exp (Warsz); 2005 Dec 25; 53(3):226-33. PubMed ID: 15995583
    [Abstract] [Full Text] [Related]

  • 36. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H, Marshall NA, Mills KH.
    Oncogene; 2008 Jan 07; 27(2):168-80. PubMed ID: 18176598
    [Abstract] [Full Text] [Related]

  • 37. Antigen presentation and dendritic cell biology in malaria.
    Stevenson MM, Urban BC.
    Parasite Immunol; 2006 Jan 07; 28(1-2):5-14. PubMed ID: 16438671
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dendritic cells and their role in cancer immunotherapy.
    Jalili A.
    Iran J Immunol; 2007 Sep 07; 4(3):127-44. PubMed ID: 17767012
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.